1. Home
  2. Our Firm
  3. News
  4. Guggenheim Securities Expands Healthcare Investment Banking & Advisory Practice

Our Firm

August 08, 2012

Guggenheim Securities Expands Healthcare Investment Banking & Advisory Practice

Appointments Represent Commitment to Strengthening a Cornerstone of the Firm’s Investment Banking Platform

Guggenheim Partners, LLC (“Guggenheim”), a global diversified financial services firm, today announced the appointments of Stuart Duty, Ron Gerber and Barry Shin to Guggenheim Securities’ healthcare investment banking and advisory team.

Based in New York, Messrs. Duty, Gerber and Shin join an existing team led by Alan Schwartz, Executive Chairman of Guggenheim Partners, and Ken Springer, Senior Managing Director.

“Stuart, Ron and Barry will add significant expertise to our growing healthcare platform,” said Mr. Schwartz. “This sector is core to our investment banking business, and their deep industry relationships and experience, especially in equity new issuance and life sciences M&A, will be invaluable as we continue to expand our franchise.”

With over 20 years of experience in the life sciences sector, Mr. Duty joins as a Senior Managing Director with responsibility for helping build the healthcare practice. Previously, he was Co-Head of Healthcare Investment Banking at Piper Jaffray. Prior to that, Mr. Duty held senior-level positions in healthcare investment banking at Montgomery Securities and Kidder Peabody & Co. Also from Piper Jaffray, Messrs. Gerber and Shin are joining Guggenheim Securities as Managing Director and Vice President, respectively. Together, they have over 25 years experience advising specialty pharmaceutical and biotechnology companies across a range of financing and M&A transactions.

“Ron, Barry and I are pleased to join the Guggenheim Securities team,” added Mr. Duty. “The firm’s accomplishments in the healthcare sector, as well as the steady growth of the entire investment banking franchise, are highly regarded throughout the industry. We look forward to building on the success with new mandates and advisory relationships.”

Since its launch in 2009, Guggenheim Securities’ healthcare investment banking and advisory practice has advised Pfizer on its $2.4 billion sale of Capsugel to KKR and Merck KGaA on its $7 billion acquisition of Millipore, in addition to numerous mid-market transactions. Guggenheim Securities is also building a healthcare-focused sales and trading team, and the firm publishes healthcare market commentary focused on regulatory and legislative issues through its Washington Research Group.

About Guggenheim Partners
Guggenheim Partners, LLC is a privately held global financial services firm with more than $160 billion in assets under management. The firm provides asset management, investment banking and capital markets services, insurance, institutional finance and investment advisory solutions to institutions, governments and agencies, corporations, investment advisors, family offices and individuals. Guggenheim Partners is headquartered in New York and Chicago and serves clients around the world from more than 25 offices in nine countries. For more information about Guggenheim Partners, visit www.guggenheimpartners.com.

Media Contacts:

Thomas S. Mulligan
Sitrick And Company
212.573.6100
thomas_mulligan@sitrick.com

Terry Fahn
Sitrick And Company
310.788.2850
terry_fahn@sitrick.com



November 15, 2018

Glen Santangelo to Join Guggenheim Securities as Healthcare Analyst

Guggenheim Securities, the investment banking and capital markets division of Guggenheim Partners, announced today that Glen Santangelo will join the firm in January as a Managing Director in a planned expansion of the firm’s Healthcare Research team. Mr. Santangelo will focus on the coverage of Healthcare IT and Distribution companies in close collaboration with the growing therapeutics and services team.

Read More

October 15, 2018

Guggenheim Partners Selects Second Cohort of Network for Social Innovation

NEW YORK - Guggenheim Partners is proud to announce the selection of four non-profit organizations for the second cohort of the Network for Social Innovation. The Network for Social Innovation is a Corporate Social Responsibility venture strategy that identifies promising, early-stage organizations using innovative solutions to solve enduring social problems. It recently won WealthManagement.com’s “Corporate Social Responsibility/Diversity” Award for an Asset Manager.

Read More

October 15, 2018

Guggenheim Fourth Quarter 2018 High-Yield and Bank Loan Outlook: Strong Earnings Growth Is Masking the Rise in Borrowing Costs

NEW YORK, NY – Guggenheim Investments, the global asset management and investment advisory business of Guggenheim Partners, today provided its Fourth Quarter 2018 High-Yield and Bank Loan Outlook.
 

Read More



© 2018 Guggenheim Partners, LLC. All rights reserved. Guggenheim, Guggenheim Partners and Innovative Solutions. Enduring Values. are registered trademarks of Guggenheim Capital, LLC.